Use of anti-FAM19A5 antibodies for treating fibrosis
Abstract:
The present disclosure relates to the pharmaceutical use of antagonists (e.g., an antibody or antigen-binding portion thereof) that specifically bind to FAM19A5 to treat or to diagnose a fibrosis and/or a fibrosis-associated disease in a subject in need thereof.
Information query
Patent Agency Ranking
0/0